Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Premium Content
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

R-ONE

Shanghai MicroPort MedBot announced on Wednesday its R-ONE Vascular Interventional Surgical Robot jointly developed with France’s Robocath S.A.S has been approved by China’s National Medical Products Administration.

FAST NEWS: MicroPort MedBot vascular surgical robot approved in China

The latest: Shanghai MicroPort MedBot (Group) Co. Ltd. (2522.HK) announced on Wednesday its R-ONE Vascular Interventional Surgical Robot jointly developed with France’s Robocath S.A.S has been approved by China’s National Medical…
December 14, 2023
2252.HK

Recent Articles

Shanghai MicroPort MedBot announced on Wednesday its R-ONE Vascular Interventional Surgical Robot jointly developed with France’s Robocath S.A.S has been approved by China’s National Medical Products Administration.
December 14, 2023

FAST NEWS: MicroPort MedBot vascular surgical robot approved in China

2252.HK

RELATED ARTICLES

  1. December 3, 2024
    BRIEF: MicroPort MedBot raises $35 million in share placement at 20% discount
    2252.HK
  2. December 2, 2024
    Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
    1952.HK
  3. February 18, 2025
    BRIEF: Yimutian approved by China for Nasdaq IPO
  4. January 17, 2025
    Shanghai family feud ties up $1 billion in property, offers lesson for investors
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Premium Content
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2024 Bamboo Works. All rights reserved.